PRCT vs INMD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 14, 2026

PRCT

29.8
AI Score
VS
INMD Wins

INMD

58.7
AI Score

Investment Advisor Scores

PRCT

30score
Recommendation
SELL

INMD

59score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric PRCT INMD Winner
Revenue 308.05M 370.50M INMD
Net Income -95,572 93.83M INMD
Gross Margin 63.7% 78.5% INMD
Net Margin -0.0% 25.3% INMD
Operating Income -103.86M 85.39M INMD
ROE -0.0% 13.7% INMD
ROA -0.0% 12.2% INMD
Total Assets 508.08M 766.43M INMD
Cash 286.50M 302.54M INMD
Current Ratio 6.85 9.88 INMD
Free Cash Flow -58.34M 84.28M INMD

Relative Price Performance (Last 90 Days)

PRCT 1M: +28.0% · 3M: -26.3% INMD 1M: -0.4% · 3M: +9.9%

Current Technical Phase

PRCT

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 53.7 · Price: $21.36

INMD

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.0% over 20 days), RSI 51

RSI (14): 51.4 · Price: $15.11

Fundamentals Snapshot

Metric PRCT INMD
Market Cap
Forward P/E -18.8 11.0
Trailing P/E 12.4
Revenue (TTM)
Revenue Growth 0.2% 0.0%
Gross Margin 0.6% 0.8%
Operating Margin -0.3% 0.1%
EPS -1.95 1.20
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, INMD is currently the stronger investment candidate, winning 11 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.